Yale Cancer Center Smilow Cancer Hospital

EP. 11: Dr. Silber on the Importance of Improving Clinical Trial Inclusivity in Breast Cancer

September 28th 2021

Andrea L. Silber, MD, discusses the importance of improving clinical trial inclusivity in breast cancer.

EP. 12: Dr. Lustberg Discusses Ongoing Research in Breast Cancer

September 28th 2021

Maryam Lustberg, MD, MPH, discusses ongoing research in breast cancer.

EP. 13: Margaret Gilshannon named Deputy Director for Finance & Administration at Yale Cancer Center

October 18th 2021

Margaret Gilshannon, MHA, has been appointed Deputy Director for Finance & Administration at Yale Cancer Center.

EP. 14: Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs

October 22nd 2021

The National Institutes of Health has awarded a grant to fund cellular senescence research in lymphoid organs at Yale Cancer Center.

EP. 15: Eric P. Winer to lead Yale Cancer Center and Smilow Cancer Hospital

November 8th 2021

Eric P. Winer, MD, will be appointed next director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital at Yale New Haven, effective February 1, 2022.

EP. 16: Dr. Parker Discusses the Importance of Optimizing Treatment in Multiple Myeloma

November 10th 2021

Terri Parker, MD, discusses considerations to optimize treatment in multiple myeloma.

EP. 17: Yale Cancer Center Study Shows New Strategy to Boost Immune System to Fight Melanoma

November 15th 2021

Findings from a new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity, which could help develop a new treatment strategy to benefit patients with melanoma and other cancers.

EP. 18: Dr. Fernandez on the Need to Refine Immunohistochemistry Testing in HER2+ Breast Cancer

December 14th 2021

Aileen I. Fernandez, PhD, discusses the need to refine immunohistochemistry testing in HER2-positive breast cancer.

EP. 19: Dr. Fernandez on the Utility of Trastuzumab Deruxtecan in HER2-Low Breast Cancer

December 22nd 2021

Aileen I. Fernandez, PhD, discusses the utility of fam-trastuzumab deruxtecan-nxki in HER2-low breast cancer.

EP. 20: Immunotherapy Advances Drive Progress in Lung Cancer Treatment

February 5th 2022

In the past 2 years, key data from clinical trials in advanced lung cancer have demonstrated that immunotherapy has expanded the bounds of the armamentarium for the treatment of several lung cancers.